Nn1436-4625
Research payments
$6,261,482
Through program year 2022, $6,261,482 in research payments was reported against Nn1436-4625, across 15,854 payments, paid by Novo Nordisk AS.
- Paid by
- Novo Nordisk AS
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $2,860,494 | 4,797 |
| 2021 | Research | $3,400,988 | 11,057 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Laura Akright Live Oak, TX Named on 651 payments
- Peter Bressler Dallas, TX Named on 620 payments
- Tira Chaicha-Brom Austin, TX Named on 609 payments
- Sam Lerman Fort Lauderdale, FL Named on 565 payments
- David Klonoff Burlingame, CA Named on 560 payments
- Khurram Wadud Jacksonville, FL Named on 534 payments
- Anna Chang Concord, CA Named on 524 payments
- Amer Al Karadsheh Houston, TX Named on 475 payments
- Samer Nakhle Las Vegas, NV Named on 468 payments
- Ronald Brazg Renton, WA Named on 438 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.